306 related articles for article (PubMed ID: 20588085)
1. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
Gattu S; Maibach HI
Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
[TBL] [Abstract][Full Text] [Related]
2. Enhanced absorption through damaged skin: an overview of the in vitro human model.
Gattu S; Maibach HI
Skin Pharmacol Physiol; 2010; 23(4):171-6. PubMed ID: 20185974
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin.
Higaki K; Nakayama K; Suyama T; Amnuaikit C; Ogawara K; Kimura T
Int J Pharm; 2005 Jan; 288(2):227-33. PubMed ID: 15620862
[TBL] [Abstract][Full Text] [Related]
4. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.
Nielsen JB; Nielsen F; Sørensen JA
Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442
[TBL] [Abstract][Full Text] [Related]
5. Age-related percutaneous penetration part 1: skin factors.
Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
Skin Therapy Lett; 2012 May; 17(5):1-5. PubMed ID: 22622279
[TBL] [Abstract][Full Text] [Related]
6. Breaching the skin's barrier to drugs.
Barry BW
Nat Biotechnol; 2004 Feb; 22(2):165-7. PubMed ID: 14755286
[No Abstract] [Full Text] [Related]
7. Topical delivery of cosmetics and drugs. Molecular aspects of percutaneous absorption and delivery.
Förster M; Bolzinger MA; Fessi H; Briançon S
Eur J Dermatol; 2009; 19(4):309-23. PubMed ID: 19443302
[TBL] [Abstract][Full Text] [Related]
8. Discovery of transdermal penetration enhancers by high-throughput screening.
Karande P; Jain A; Mitragotri S
Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
[TBL] [Abstract][Full Text] [Related]
9. The tape-stripping technique as a method for drug quantification in skin.
Escobar-Chávez JJ; Merino-Sanjuán V; López-Cervantes M; Urban-Morlan Z; Piñón-Segundo E; Quintanar-Guerrero D; Ganem-Quintanar A
J Pharm Pharm Sci; 2008; 11(1):104-30. PubMed ID: 18445368
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous penetration].
Jamoulle JC
Ann Dermatol Venereol; 1988; 115(5):627-40. PubMed ID: 3058009
[No Abstract] [Full Text] [Related]
11. Penetration properties and safety aspects of topically applied products.
Fluhr J; Lademann J
Skin Pharmacol Physiol; 2008; 21(6):293. PubMed ID: 18997482
[No Abstract] [Full Text] [Related]
12. Overcoming the stratum corneum: the modulation of skin penetration. A review.
Trommer H; Neubert RH
Skin Pharmacol Physiol; 2006; 19(2):106-21. PubMed ID: 16685150
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
14. Response to Farahmand and Maibach's corrigenda.
Kissel JC; Bunge AL
Int J Pharm; 2010 Oct; 398(1-2):254-6. PubMed ID: 20600728
[No Abstract] [Full Text] [Related]
15. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
Benfeldt E
Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
[TBL] [Abstract][Full Text] [Related]
16. Status of terpenes as skin penetration enhancers.
Aqil M; Ahad A; Sultana Y; Ali A
Drug Discov Today; 2007 Dec; 12(23-24):1061-7. PubMed ID: 18061886
[TBL] [Abstract][Full Text] [Related]
17. Age-related percutaneous penetration part 2: effect of age on dermatopharmacokinetics and overview of transdermal products.
Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
Skin Therapy Lett; 2012 Jun; 17(6):5-7. PubMed ID: 22735504
[TBL] [Abstract][Full Text] [Related]
18. Modeling the human skin barrier--towards a better understanding of dermal absorption.
Jepps OG; Dancik Y; Anissimov YG; Roberts MS
Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
[TBL] [Abstract][Full Text] [Related]
19. Iontophoretic drug delivery.
Kalia YN; Naik A; Garrison J; Guy RH
Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
[TBL] [Abstract][Full Text] [Related]
20. The usual suspects-influence of physicochemical properties on lag time, skin deposition, and percutaneous penetration of nine model compounds.
Bo Nielsen J; Ahm Sørensen J; Nielsen F
J Toxicol Environ Health A; 2009; 72(5):315-23. PubMed ID: 19184747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
